Predictive Test For Adverse Drug Reaction Nearing Clinical Use - Woosley
Executive Summary
A predictive gene chip test to detect potential adverse drug reactions in women is nearing clinical use, Georgetown University Department of Pharmacology Chairman Raymond Woosley, MD/PhD, reported at a Senate Health Committee hearing on adverse drug events Feb. 1.